Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 17;34(4):328-335.
doi: 10.5152/pcp.2024.24953.

Evaluating Body Image Disturbance and Its Influencing Factors in Breast Cancer Patients Following Unilateral Mastectomy

Affiliations

Evaluating Body Image Disturbance and Its Influencing Factors in Breast Cancer Patients Following Unilateral Mastectomy

Weidan Xu et al. Psychiatry Clin Psychopharmacol. .

Abstract

Background: Patients with unilateral breast loss after single mastectomy for breast cancer may have body image disorders such as surgical lymphedema, flap ischemia, and spinal deformity, resulting in negative emotions such as depression, inferiority, and social dysfunction. This study mainly investigated and analyzed the status quo and influencing factors of body image disorder in breast cancer patients after single mastectomy.

Methods: This study is a cross-sectional study. Breast cancer patients admitted from May 2023 to April 2024 were selected as the research subjects. Data were collected with a general information questionnaire, the Body Image Scale (BIS), the Self-Image Scale, the Self-Acceptance Questionnaire, and the Perceived Social Support Scale. Based on the scores, the research subjects were divided into a body image disturbance group and a non-disturbance group. Univariate and multiple logistic regression analyses were conducted to analyze the influencing factors of body image disturbances in breast cancer patients.

Results: One hundred fifty questionnaires were distributed in this study, and 146 valid questionnaires were collected. Among the 146 patients, 51 (34.93%) experienced body image disturbances after surgery, while 95 (65.07%) did not. The results of univariate and multiple logistic regression analyses showed that educational level, lymphedema in the affected limb, intimate relationships, self-image, self-acceptance, and perceived social support scores were independent risk factors for body image disturbances in breast cancer patients after surgery (P < .05).

Conclusion: Body image disturbances in breast cancer patients who undergo unilateral mastectomy need further improvement. Educational level, lymphedema in the affected limb, intimate relationships, self-image, self-acceptance, and perceived social support are the main influencing factors.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests: The authors have no conflict of interest to declare.

Figures

Figure 1.
Figure 1.
Case flow chart.
Figure 2.
Figure 2.
BID Occurrence in Postoperative Breast Cancer Patients. Note: BID stands for Body Image Disturbance.

Similar articles

References

    1. Rouhani M, Ramshini S, Omidi M. The Psychiatric Drug Lithium Increases DNA Damage and Decreases Cell Survival in MCF-7 and MDA-MB-231 Breast Cancer Cell Lines Expos ed to Ionizing Radiation. Curr Mol Pharmacol. 2019;12(4):301 310. (10.1016/j.annonc.2023.11.016) - DOI - PubMed
    1. LIU J, PANG K, HE F. Weighted gene co-expression network analysis identifies a novel immune-related gene signature and nomogram to predict the survival and immune infiltration status of breast cancer. BIOCELL. 2022;46(7):1661 1673. (10.1016/j.annonc.2023.11.016) - DOI
    1. Naeimzadeh Y, Heidari Z, Razban V, Khajeh S. Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast Cancer with Focus on Triple-negative Breast Cancer. Curr Mol Pharmacol. 2024;17(1):e18761429263841. (10.1016/j.annonc.2023.11.016) - DOI - PubMed
    1. Hashemi F, Zarrabi A, Zabolian A, et al. Novel Strategy in Breast Cancer Therapy: Revealing The Bright Side of Ginsenosides. Curr Mol Pharmacol. 2021;14(6):1093 1111. (10.1016/j.breast.2022.08.010) - DOI - PubMed
    1. FAN K, WENG J. The progress of combination therapy with immune checkpoint inhibitors in breast cancer. BIOCELL. 2023;47(6):1199 1211. (10.1016/j.breast.2022.08.010) - DOI

LinkOut - more resources